Skip to main content
EURAXESS

MSCA-IF-2020 Expression of Interest in Paediatric Virology

IdiPAZ The Human Resources Strategy for Researchers
16 Apr 2020

Hosting Information

Offer Deadline
EU Research Framework Programme
H2020 / Marie Skłodowska-Curie Actions
Country
Spain
City
Madrid

Organisation/Institute

Organisation / Company
IdiPAZ
Department
Infectious diseases and Immunity
Laboratory
PEDIATRIC RESPIRATORY, SYSTEMIC AND NEUROLOGICAL INFECTIONS & HOST IMMUNE RESPONSE
Is the Hosting related to staff position within a Research Infrastructure?
No

Contact Information

Organisation / Company Type
Public Research Institution
Website
Email
ccalvorey@gmail.com
international.projects@idipaz.es
State/Province
Comunidad de Madrid
Postal Code
28046
Street
Paseo de la Castellana 261

Description

Our group aims to generate knowledge directly related to the identification of early risk biomarkers and occurrence of viral diseases and will be translatable to pediatric patients with special attention to particularly vulnerable groups such as infants, children with risk factors and immunocompromised children, for generating effective prevention in these cases. We form a multidisciplinary group with pediatricians of different levels of care, covering the outpatient, the hospitalized child, the neonate and the risk patient, working together with top-level virologists (National Center for Microbiology), immunologists and other research groups.

We are looking for proactive postdoctoral biologists, computer scientists or bioinformaticians who are in position to develop a research project that helps us with new tools and perspectives, taking advantage of our data pools derived from metagenomics and molecular biology results, particularly:

  • methods for detecting and characterizing viral metagenomics. Coronaviruses are now one of our priorities;
  • relations between relative frequencies of high-throughput sequenced viruses with the severity of the respiratory infections in children (inpatients and outpatients);
  • evaluation of risk conditions in viral infections (newborn, chronic lung diseases, immunodefiencies, oncologic patients…) by combination of different data and new technologies, such as echography;
  • interleukins profiling in infants with respiratory viral infections and its correlation with the development of recurrent wheezing in the first years of life;
  • detection and characterization of enterovirus (EV) and parechovirus (PeV) sero/genotypes that cause severe diseases in children (acute flaccid paralysis, meningitis, encephalitis, respiratory illnesses, myocarditis or sepsis);
  • biological characterisation of the mechanisms of the pathogenic variability of those EV and PeV viruses;
  • neurological development in children with EV and PeV infections.

We offer and stimulating research environment devoted to streamline basic results into clinical impacts.

Documents to be sent before 29/05/2020:

  • Curriculum vitae (2 pages maximum)
  • Letter of motivation (1 page maximum)